Maco Pharma International GmbH Sustainability Profile
Maco Pharma International GmbH, a leading name in the medical technology sector, is headquartered in Germany and operates extensively across Europe and beyond. Founded in 1985, the company has established itself as a key player in the development and manufacturing of innovative solutions for blood and cell therapies, as well as transfusion medicine. Maco Pharma's core offerings include a range of medical devices and consumables designed to enhance the safety and efficiency of blood management processes. Their commitment to quality and innovation has positioned them as a trusted partner in healthcare, with notable achievements in regulatory compliance and product development. With a strong market presence, Maco Pharma continues to advance the field of transfusion medicine, ensuring better patient outcomes worldwide.
DitchCarbon Score
How does Maco Pharma International GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Maco Pharma International GmbH's score of 15 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Maco Pharma International GmbH's reported carbon emissions
Maco Pharma International GmbH, headquartered in Germany, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Maco Pharma may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is challenging to assess Maco Pharma's position relative to its peers in the pharmaceutical sector.
How Carbon Intensive is Maco Pharma International GmbH's Industry?
How Carbon Intensive is Maco Pharma International GmbH's Location?
Maco Pharma International GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Maco Pharma International GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
